We revealed a new mechanism by which the U3/ZBTB7A/HK2 LDHA pathway promotes tumorigenesis in IDH1WT GBM cells, thus providing new targets and strategies for the treatment of IDH1WT GBM. Here, HK2 is linked to glioblastoma.